KALKOFEN DONALD A. (Chief Financial Officer) received a stock award from PROTAGONIST THERAPEUTICS, INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/17/2022ACC: 0001104659-22-024841
Officer· Chief Financial Officer
Since May 2019
+52.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
52.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+7.50K
Price / share
—
Trade value
—
% of position
68.1%
2/15/2022
11.02K→18.52K
Total
Net shares
+7.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/15/2022 | A · Award | +7.50K | — | — | 68.1% | 11.02K | 18.52K |
| Total | +7.50K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
45K shares
Shares
+45K
Strike price
28.73
Held after
45K
Exercisable
—
2/15/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock45K shares | 2/15/2022 | A · Award | +45K | 28.73 | — | 45K |